ATE258792T1 - Diät mit hohem lipidgehalt - Google Patents

Diät mit hohem lipidgehalt

Info

Publication number
ATE258792T1
ATE258792T1 AT00956522T AT00956522T ATE258792T1 AT E258792 T1 ATE258792 T1 AT E258792T1 AT 00956522 T AT00956522 T AT 00956522T AT 00956522 T AT00956522 T AT 00956522T AT E258792 T1 ATE258792 T1 AT E258792T1
Authority
AT
Austria
Prior art keywords
composition
high lipid
medicament
lipid diet
nutritional product
Prior art date
Application number
AT00956522T
Other languages
English (en)
Inventor
Marco Turini
Claudia Roessle
Denis Breuille
Gayle Crozier-Willi
Paul-Andre Finot
Myriam Richelle
Guy Dutot
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238988&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE258792(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE258792T1 publication Critical patent/ATE258792T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
AT00956522T 1999-09-13 2000-09-07 Diät mit hohem lipidgehalt ATE258792T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99118173A EP1090636A1 (de) 1999-09-13 1999-09-13 Diät mit hohem Lipidgehalt
PCT/EP2000/008731 WO2001019356A2 (en) 1999-09-13 2000-09-07 High lipid diet

Publications (1)

Publication Number Publication Date
ATE258792T1 true ATE258792T1 (de) 2004-02-15

Family

ID=8238988

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956522T ATE258792T1 (de) 1999-09-13 2000-09-07 Diät mit hohem lipidgehalt

Country Status (13)

Country Link
US (2) US6995189B1 (de)
EP (2) EP1090636A1 (de)
CN (1) CN1222284C (de)
AT (1) ATE258792T1 (de)
AU (1) AU6843000A (de)
BR (1) BR0013958A (de)
CA (1) CA2384859C (de)
DE (1) DE60008127T2 (de)
ES (1) ES2213036T3 (de)
HK (1) HK1052298B (de)
MX (1) MXPA02002728A (de)
PT (1) PT1216041E (de)
WO (1) WO2001019356A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758893B2 (en) 2001-07-27 2010-07-20 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
DK1589834T3 (da) * 2003-02-05 2007-06-18 Nutricia Nv Enteral komposition til forebyggelse og/eller behandling af sepsis
EP1811867A2 (de) * 2004-11-12 2007-08-01 N.V. Nutricia Protein- und fett-fraktion enthaltende lebensmittelzusammensetzung zur schnellen verminderung von entzündlichen reaktionen
US8821947B2 (en) * 2006-06-01 2014-09-02 Howard W. Selby, III Cholesterol-reducing diet
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
CN103494196A (zh) * 2006-10-19 2014-01-08 雀巢产品技术援助有限公司 老年人的长期喂养
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002166A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Improving memory in subjects with mini-mental state examination of 24-26
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
BRPI0822111B8 (pt) 2007-12-20 2021-05-25 Nutricia Nv composição líquida, e, uso de uma composição líquida
EP2311486A1 (de) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 zur Verwendung in der Dünndarm- und Muskelwiederherstellung
DK2409695T3 (en) 2010-07-05 2018-05-28 Beth Israel Deaconess Medical Ct Inc SN-2-MONOACYLGYLYCEROLS AND LIPID MALABSORPTION
WO2012138212A1 (en) 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
CN104026591A (zh) * 2014-04-04 2014-09-10 上海英莱腾医药研究有限公司 一种含中链甘油三酯的多功能蛋白食品组合物
US20180169052A1 (en) * 2014-07-23 2018-06-21 The Food Science Institute Foundation Agent for improving brain function and agent for preventing or treating cognitive impairment
US11162708B2 (en) * 2015-11-16 2021-11-02 Genie Enterprise Ltd. Apparatus for rapid heating of liquids
US20180185317A1 (en) * 2016-12-29 2018-07-05 Immodulon Therapeutics Limited Immunotherapeutic agent
CN108402467A (zh) * 2018-03-01 2018-08-17 苏州恒瑞健康科技有限公司 一种提高肿瘤患者营养需求的组合物及其应用、用于提高外源性脂肪利用率的食品及药品
EP3820463A1 (de) * 2018-07-10 2021-05-19 Société des Produits Nestlé S.A. Mct-formulierungen zur erhöhung der ketonexponiertheit und verfahren zur herstellung und verwendung solcher formulierungen
CN108703180A (zh) * 2018-08-29 2018-10-26 西安瑞仁生物技术有限公司 一种高纤、低碳、高脂的生酮饼干及其制备方法
JP2022534471A (ja) * 2019-05-31 2022-08-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物における健康効果を提供するためのｍｃｔベースの栄養ブレンド

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055446A (en) 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
WO1997019683A1 (en) * 1995-11-28 1997-06-05 B. Braun Melsungen Ag Hydrolysis-optimized lipid emulsions and use thereof
EP0852913A1 (de) * 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Zusammensetzung und Methode zur Behandlung inflammatorischer Zustände des Magen-Darm-Traktes
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis

Also Published As

Publication number Publication date
US6995189B1 (en) 2006-02-07
US20050281864A1 (en) 2005-12-22
CN1390125A (zh) 2003-01-08
ES2213036T3 (es) 2004-08-16
DE60008127T2 (de) 2004-09-09
AU6843000A (en) 2001-04-17
MXPA02002728A (es) 2002-08-30
US7691906B2 (en) 2010-04-06
DE60008127D1 (de) 2004-03-11
CN1222284C (zh) 2005-10-12
PT1216041E (pt) 2004-05-31
WO2001019356A2 (en) 2001-03-22
EP1216041B1 (de) 2004-02-04
EP1216041A2 (de) 2002-06-26
HK1052298A1 (en) 2003-09-11
CA2384859C (en) 2007-07-03
WO2001019356A3 (en) 2001-05-17
BR0013958A (pt) 2002-05-14
EP1090636A1 (de) 2001-04-11
HK1052298B (zh) 2006-07-07
CA2384859A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
DE60008127D1 (de) Diät mit hohem lipidgehalt
GB2221843B (en) Fatty acid composition
MXPA01006455A (es) Composiciones para el cuidado de la piel que contienen acido linoleico cis-9, trnas-11.
EP1787532A3 (de) Gemische von mikrobiellen Ölen und deren Verwendungen
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
DE3486235D1 (de) Fettsäure-Zusammensetzungen.
DE68905863D1 (de) Zusammensetzungen essentieller fettsaeuren.
DE69935995D1 (de) Polyungesättigen fettsäuren nährungsergänzung
MY109928A (en) Fatty acid treatment
IE893413L (en) Glucan dietary additives
EP0175468A3 (de) Eicosanoide zur Verwendung bei der Krebstherapie
IT1187687B (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
ATE212194T1 (de) Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
ATE45091T1 (de) Pharmazeutische zubereitung mit speziellen 1,2diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich.
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
TH15810A (th) สูตรผสมที่มีกรดแฟททีชนิดไม่อิ่มตัว
MY129218A (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
TH23727A (th) การยับยั้งเฮลิโคแบคเตอร์

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1216041

Country of ref document: EP